These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36513368)

  • 1. Radiomic features of gray matter in never-treated first-episode schizophrenia.
    Zhu F; Xiao Y; Tao B; Gao Z; Gao X; Zhao Q; Zhang Q; Tang B; Zhang X; Zhao Y; Bishop JR; Sweeney JA; Lui S
    Cereb Cortex; 2023 May; 33(10):5957-5967. PubMed ID: 36513368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of magnetic resonance imaging on the gray matter and resting-state function in prodromal and first-episode schizophrenia.
    Lian N; Lv H; Guo W; Shen Y; Wu R; Liu Y; Zhu F; Hu M; Ou J; Zhao J
    Am J Med Genet B Neuropsychiatr Genet; 2018 Sep; 177(6):537-545. PubMed ID: 30105860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting.
    Leung M; Cheung C; Yu K; Yip B; Sham P; Li Q; Chua S; McAlonan G
    Schizophr Bull; 2011 Jan; 37(1):199-211. PubMed ID: 19759093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis.
    Shah C; Zhang W; Xiao Y; Yao L; Zhao Y; Gao X; Liu L; Liu J; Li S; Tao B; Yan Z; Fu Y; Gong Q; Lui S
    Psychol Med; 2017 Feb; 47(3):401-413. PubMed ID: 27776571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.
    Torres US; Duran FL; Schaufelberger MS; Crippa JA; Louzã MR; Sallet PC; Kanegusuku CY; Elkis H; Gattaz WF; Bassitt DP; Zuardi AW; Hallak JE; Leite CC; Castro CC; Santos AC; Murray RM; Busatto GF
    Neuroimage Clin; 2016; 12():1-15. PubMed ID: 27354958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupted structural covariance network in first episode schizophrenia patients: Evidence from a large sample MRI-based morphometric study.
    Zhang X; Liu W; Guo F; Li C; Wang X; Wang H; Yin H; Zhu Y
    Schizophr Res; 2020 Oct; 224():24-32. PubMed ID: 33203611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression.
    Chan RC; Di X; McAlonan GM; Gong QY
    Schizophr Bull; 2011 Jan; 37(1):177-88. PubMed ID: 19633214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.
    Zhao C; Zhu J; Liu X; Pu C; Lai Y; Chen L; Yu X; Hong N
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():27-32. PubMed ID: 29292241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies.
    Dietsche B; Kircher T; Falkenberg I
    Aust N Z J Psychiatry; 2017 May; 51(5):500-508. PubMed ID: 28415873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered voxel-wise gray matter structural brain networks in schizophrenia: Association with brain genetic expression pattern.
    Liu F; Tian H; Li J; Li S; Zhuo C
    Brain Imaging Behav; 2019 Apr; 13(2):493-502. PubMed ID: 29728906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural brain imaging abnormalities correlate with positive symptom in schizophrenia.
    Zhang M; Xiang H; Yang F; Fan H; Fan F; Song J; Wang Z; Tan Y; Tang S; Tan S; Elliot Hong L
    Neurosci Lett; 2022 Jun; 782():136683. PubMed ID: 35595192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive brain structural changes after the first year of treatment in first-episode treatment-naive patients with deficit or nondeficit schizophrenia.
    Lei W; Kirkpatrick B; Wang Q; Deng W; Li M; Guo W; Liang S; Li Y; Zhang C; Li X; Zhang P; Li Z; Xiang B; Chen J; Hu X; Zhang N; Li T
    Psychiatry Res Neuroimaging; 2019 Jun; 288():12-20. PubMed ID: 31059954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
    Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
    J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia.
    Guo X; Li J; Wang J; Fan X; Hu M; Shen Y; Chen H; Zhao J
    Schizophr Res; 2014 Feb; 152(2-3):339-43. PubMed ID: 24439000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of First-Episode Schizophrenia Using Multimodal Brain Features: A Combined Structural and Diffusion Imaging Study.
    Liang S; Li Y; Zhang Z; Kong X; Wang Q; Deng W; Li X; Zhao L; Li M; Meng Y; Huang F; Ma X; Li XM; Greenshaw AJ; Shao J; Li T
    Schizophr Bull; 2019 Apr; 45(3):591-599. PubMed ID: 29947804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic influence of the DRD3 rs6280 polymorphism (Ser9Gly) on functional connectivity and gray matter volume of the hippocampus in patients with first-episode, drug-naïve schizophrenia.
    Kang Y; Zhang Y; Huang K; Wang Z
    Behav Brain Res; 2023 Feb; 437():114124. PubMed ID: 36154848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared and distinct gray matter abnormalities in schizophrenia, schizophrenia relatives and bipolar disorder in association with cognitive impairment.
    Knöchel C; Stäblein M; Prvulovic D; Ghinea D; Wenzler S; Pantel J; Alves G; Linden DE; Harrison O; Carvalho A; Reif A; Oertel-Knöchel V
    Schizophr Res; 2016 Mar; 171(1-3):140-8. PubMed ID: 26833265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between first-episode drug-naïve schizophrenia and age based on gray matter volume and its molecular analysis: a multimodal magnetic resonance imaging study.
    Chen J; Wei Y; Xue K; Han S; Wang C; Wen B; Cheng J
    Psychopharmacology (Berl); 2023 Apr; 240(4):813-826. PubMed ID: 36719459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematically mapping gray matter abnormal patterns in drug-naïve first-episode schizophrenia from childhood to adolescence.
    Fan YS; Xu Y; Li Q; Chen Y; Guo X; Yang S; Guo J; Sheng W; Wang C; Gao Q; Chen H
    Cereb Cortex; 2023 Feb; 33(4):1452-1461. PubMed ID: 35396845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gray matter abnormalities in language processing areas and their associations with verbal ability and positive symptoms in first-episode patients with schizophrenia spectrum psychosis.
    Jung S; Lee A; Bang M; Lee SH
    Neuroimage Clin; 2019; 24():102022. PubMed ID: 31670071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.